About

:::

About Us

Company Profile

Founded in 2001, UTRUST brings over 20 years of rich experience and technical expertise, dedicated to providing premium products and services to global CNC customers and industry partners.

We specialize in semiconductor equipment design and services, alongside providing testing support for high-speed Very Large Scale Integration (VLSI) products. UTRUST's design and maintenance capabilities have earned certifications from major semiconductor leaders, extending our business footprint across the United States, Singapore, Malaysia, and China. In 2018, the core UTRUST team officially expanded to focus on solutions for the Internet of Things (IoT), cloud computing, edge computing, Industrial PC (IPC) module design, telecommunications, and embedded systems.

Looking ahead into the next two decades, genomic technology is set to profoundly transform human wellness and living experiences, marking our commitment toward sustainable, long-term growth. We are fully invested in driving cutting-edge genetic R&D to deliver life-enhancing products and build a prosperous, hope-filled future together.

UTRUST About Us

Group Architecture & Strategic Layout

SL GROUP Ecosystem
SL GROUP is anchored by dual growth engines: High-Tech and Life Sciences. Through cross-industry vertical integration and global capital market strategic layout, we foster a forward-looking corporate ecosystem.
 I. High-Tech Sector
SEMICONDUCTOR
SL LINK

Deeply integrated into the semiconductor supply chain, offering test interface design, precision hardware manufacturing, and global supply services.

TESTING
RamSun

Specialized in high-speed memory test solutions and equipment R&D, delivering large-scale measurement validation and turnkey OEM services.

DRAM
UTRUST

Focusing on memory channel distribution and technology integration, providing high-speed serial signal testing and industrial cloud storage solutions.

 II. Life Sciences Sector
REGENERATIVE MEDICINE / PHARMA
SL-MEDICAL

Focusing on cell therapy and innovative drug development, building high-quality cell repositories and translational medicine platforms.

BIOTECH
SLBT NASDAQ: SLBT

Leveraging US capital market entry to accelerate biotech R&D momentum and global commercial licensing.

Interested in our solutions or partnership opportunities?

Reach out to our professional team today for immediate technical assistance and inquiries.

Contact Us